Category: Press Releases

Copenhagen Infrastructure Partners (CIP), on behalf of its Flagship Funds, and Myrsky Energia (Myrsky) today announced a partnership to develop more than 1.8 GW of onshore wind power in Finland. This transaction puts Finland on track to become a European leader in the energy transition and will make a material contribution toward Finland’s 2035 carbon neutrality target.

COPENHAGEN, Denmark and HELSINKI, Finland, May 24, 2023 (GLOBE NEWSWIRE) — CIP has entered into a framework agreement with Myrsky, a Finnish developer specialising in wind power, to develop more than 1.8 GW of onshore wind power in Finland. This capacity will make a material contribution to Finland’s 2035 carbon neutrality target.

The partnership is reflective of CIP’s strategy to pursue investments which deliver the step change in scale and pace of development required to meet the ambitious targets set by governments. The portfolio of wind projects will not only contribute to Finland’s net zero ambition but also improve energy security and help strengthen communities and transform local economies through job creation and additional tax revenues.

This marks the first investment by CIP in onshore wind power in the Nordic countries.

Nischal Agarwal, Partner in CIP, said of the transaction: “We believe Finland has excellent conditions for large scale onshore wind projects and a significant ambition to decarbonise by 2035 and achieve energy security. We are pleased to partner with Myrsky who is a leading renewables developer in Finland and we look forward to our cooperation and combining our expertise to participate in Finland’s energy transition.”

Tuomas Candelin-Palmqvist, entrepreneur and founder of Myrsky, commented: “We are delighted to partner with CIP to accelerate the delivery of Myrsky’s wind power projects over the coming years. On a global scale, Finland has unique onshore wind energy potential to produce renewable electricity. Green energy investments can create industry-scale business opportunities, local welfare, and employment as well as boost our energy security. Renewable energy is the new welfare industry for Finland.”

About Copenhagen Infrastructure Partners
Founded in 2012, Copenhagen Infrastructure Partners P/S (CIP) today is the world’s largest dedicated fund manager within greenfield renewable energy investments and a global leader in offshore wind. The funds managed by CIP focuses on investments in offshore and onshore wind, solar PV, biomass and energy-from-waste, transmission and distribution, reserve capacity, storage, advanced bioenergy, and Power-to-X.

CIP manages ten funds and has to date raised approximately EUR 19 billion for investments in energy and associated infrastructure from more than 140 international institutional investors. CIP has approximately 400 employees and 11 offices around the world. For more information, visit www.cip.com

About Myrsky Energia
Founded in 2020, Myrsky Energia has over a decade of experience and deep roots in the renewables sector in Finland. Myrsky is a leading renewables developer in wind and solar power and the company has over 5 GW of wind power and 2 GW of solar power under development.

Cooperation, local presence, and respect for the nature guide Myrsky’s operations. The company employs over 30 energy professionals and has three offices in Finland. For more information, visit www.myrsky.fi

For further information, please contact:
E-mail: media@cip.com

Oliver Routhe Skov, Head of Media Relations at CIP
Phone: +45 30541227
Email: orsk@cisc.dk

Thomas Kønig, Partner – Investor Relations at CIP
Phone: +45 7070 5151
Email: tkon@cip.com

Mervi Kainulainen, Communications Manager at Myrsky
Phone: +358 40 546 1194
Email: mervi@myrsky.fi

GlobeNewswire Distribution ID 1000821645

VANCOUVER, British Columbia, May 24, 2023 (GLOBE NEWSWIRE) — Arbor Metals Corp. (“Arbor” or the “Company”) (TSXV: ABR, FWB: 432) is pleased to announce that the recent commitment made by Ford Motor Company to secure lithium from Quebec has been seen as a resounding endorsement of Arbor‘s vision for the lithium market in the region. The automaker’s announcement, which highlights their proactive approach in securing lithium production for electric vehicle (EV) manufacturing, aligns with Arbor‘s mission to be a major player in the Quebec lithium market.

Arbor fully supports the vision of automakers like Ford who are dedicated to driving the global electrification revolution. By proactively securing the essential metal required for the transition, namely lithium, these automakers are taking a significant step towards sustainable and environmentally friendly transportation solutions. The commitment to sourcing lithium from Quebec further strengthens Arbor‘s confidence in the immense potential of the region and the pivotal role it will play in the EV industry.

Ford’s decision to secure lithium production from Quebec serves as a strong validation of Arbor‘s strategic focus and underscores the Company’s dedication to being at the forefront of the lithium market. With its rich lithium deposits, Quebec has emerged as a key player in the global supply chain, and Arbor plans to capitalize on this opportunity.

Arbor is actively advancing its lithium projects in Quebec, including the flagship Jarnet Lithium project. The Company’s experienced team, coupled with its commitment to responsible and sustainable resource development, could position Arbor as a part of the lithium supply chain.

“We are excited to see major automakers recognizing the importance of securing lithium supply for their EV production. Ford’s commitment to Quebec’s lithium production reinforces our belief in the immense potential of this region,” commented Mark Ferguson, CEO of Arbor. “Arbor Metals is determined to play a significant role in meeting the growing demand for lithium and supporting the global electrification efforts.”

Arbor will continue to pursue its exploration and development activities in Quebec with a strong commitment to sustainable practices. The Company anticipates to be a key contributor to the lithium supply chain, helping to meet increased demand from automakers and driving the transition to a cleaner and greener future.

Arbor Metals Corp. is a mining exploration company specializing in the development of high-value, geographic significant mineral projects around the world. As an industry leader, it is paving the way for advanced mineral exploration as it oversees world-class mining projects. Arbor believes quality projects, combined with proven strategies and a professional team, will deliver superior results. The company holds three exceptional mineral projects.

The Jarnet lithium project, located in the James Bay region of Quebec, comprises 47 map-designated claims, covering an area of approximately 3,759 hectares. The Jarnet project is contiguous to the Corvette-FCI property, where diamond drilling has confirmed significant lithium mineralization, and represents one of the highest-profile lithium exploration projects in the sector.

For further information, contact Mark Ferguson, Chief Executive Officer, at info@arbormetals.com, or visit the Company’s website at www.arbormetalscorp.com.

On behalf of the Board,

Arbor Metals Corp.

Mark Ferguson, Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain certain “Forward-Looking Statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When or if used in this news release, the words “anticipate”, “believe”, “estimate”, “expect”, “target”, “plan”, “forecast”, “may”, “schedule” and similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to the development of the Jarnet Lithium Project, the assessment of samples from that Project, and other factors or information. Such statements represent the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance, or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

Contact Data

CONTACT:

MRKT360 INC

https://mrkt360.com

Alex Zertuche

alexz@mrkt360.com

For E.S.T Office Hours, Call 1 416-477-0587

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3618b042-01cc-4fdc-9dc6-19987e9bc55d

GlobeNewswire Distribution ID 8845204

PHOENIX, May 23, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), the North American leader in innovative flexible space and storage solutions, today announced that Tim Boswell, President and Chief Financial Officer, and Nick Girardi, Senior Director of Treasury and Investor Relations, will participate in a presentation and host private investor meetings at the Stifel Cross Sector Insight Conference in Boston, MA, on June 6, 2023. The presentation will take place at 11:30 am ET.

About WillScot Mobile Mini

WillScot Mobile Mini trades on the Nasdaq stock exchange under the ticker symbol “WSC.” Headquartered in Phoenix, Arizona, the Company is a leading business services provider specializing in innovative flexible space and storage solutions. WillScot Mobile Mini services diverse end markets across all sectors of the economy from a network of approximately 240 branch locations and additional drop lots throughout the United States, Canada, and Mexico.

Additional Information and Where to Find It

Additional information can be found on the company’s website at www.willscotmobilemini.com.

Contact Information
Investor Inquiries:		Media Inquiries:
Nick Girardi		Jake Saylor
investors@willscotmobilemini.com		jake.saylor@willscot.com

GlobeNewswire Distribution ID 8844365

Periscope by McKinsey recognized as a comprehensive pricing solution that includes strategy, analytics, technology, process optimization, and change management

NEW YORK and LONDON, May 23, 2023 (GLOBE NEWSWIRE) — McKinsey & Company today announced that Periscope by McKinsey has been recognized as a Leader in the IDC MarketScape: Worldwide Retail Price Optimization Solutions 2023 Vendor Assessment (doc #US49458922, March 2023). McKinsey was also named a Leader in the IDC MarketScape in 2021-2022 (doc #US48393721, December 2021).

The Periscope by McKinsey platform combines world-leading intellectual property, prescriptive analytics, and a suite of marketing and sales analytics solutions, including pricing and promotion. This unique combination helps companies drive revenue growth and fuels Growth, Marketing & Sales’ transformational client offerings.

Price is often the first consideration of consumers when making a purchase. For retailers, setting the right price at the right time is crucial to driving growth and profits, yet few are able to make informed decisions using real-time data and market analyses. Only 15 to 20 percent of retailers have some form of dynamic pricing capabilities.

According to the IDC MarketScape report, “Together with McKinsey’s professional services, Periscope’s customers benefit from a comprehensive pricing solution that includes strategy, analytics, technology, process optimization, and change management, which is highly tailored to the company and its goals while staying on a long-term upgrade road map. McKinsey’s solution focuses on the full impact potential with a full pricing life-cycle package.”

The IDC MarketScape report identifies some of McKinsey’s strengths:

• Sophisticated pricing, expert-focused solution: McKinsey brings together over 750 full-time employees dedicated to pricing science, with a complement of strategic consultative service. Our team’s proficiency in elasticity and the integration of rule-based capabilities create a strong user interface. And our strategic analytics tools mean long-term customer success and margin growth. We know how to push our customers to drive pricing excellence, bringing unique expertise to develop pricing capabilities.

• Customer responsiveness: McKinsey customers are highly confident that we understand their current and future needs, and are willing to invest in our platform to support future growth opportunities.

• Customer satisfaction: McKinsey customers are highly satisfied with Periscope and the sales and customer service processes. They are highly likely to recommend the company to other colleagues in the industry. Customer interviews highlight McKinsey’s ability to customize solutions to fit customer needs.

“Price optimization has become even more important as the economy emerges from the pandemic and inflationary pressure requires considered tactics that meet retailer and consumer needs. Retailers must evaluate and leverage price optimization solutions to reduce costs, maintain profitability, and continue to offer effective price points that consumers will be willing to purchase at,” said Ananda Chakravarty, vice president for Retail Insights at IDC, and author of the report. “Several factors play a part in price, and all of them lead back to driving the retail business. Retail is about selling merchandise, and price is a key driver.”

Zachary John, a partner and Periscope leader at McKinsey & Company
“As revenue growth experts, we focus on helping retailers build a data-driven operating model to make forward-looking decisions. Their ability to harness competitive intelligence and consumer insights to build, refine, and, in real-time, optimize their pricing strategy is of critical importance to protecting margins and driving growth. Our powerful combination of world-class consulting services and Periscope pricing solutions helps our clients drive analytics and insights into the economics of pricing and robust execution.”

Tobias Wachinger, a senior partner at McKinsey & Company
“As retailers and companies feel the pressure from all sides to rein in prices and adapt to inflation, the time is now to refine their pricing strategies. And what the outperformers are realizing is that they can do both – strengthen customer relationships and overall margins. To create long-term value, companies should take a nuanced approach to pricing, promotion, and assortment strategy that is grounded in rich analytics – one that can inform customer’s willingness to pay, the margin performance of a product, and service level expected from the price change. We are humbled by the IDC MarketScape’s recognition, and it’s a testament to the work we do in service of our clients and their customers.”

The 2023 IDC MarketScape for Worldwide Retail Price Optimization Solutions 2023 Vendor Assessment excerpt can be accessed here.

About IDC MarketScape:
The IDC MarketScape vendor assessment model is designed to provide an overview of the competitive fitness of ICT (information and communications technology) suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT and telecommunications vendors can be meaningfully compared. The framework also provides technology buyers with a 360-degree assessment of the strengths and weaknesses of current and prospective vendors.

About Growth, Marketing & Sales, McKinsey & Company 
The mission of the McKinsey Growth, Marketing & Sales practice is to help leaders of both consumer and business-to-business clients create Growth that Matters through meaningful transformations and marketing-driven profit. The practice helps its clients set their strategic direction, develop their marketing and sales capabilities, and connect their organization to realize the full potential of today’s omnichannel opportunities. Clients benefit from McKinsey’s experience in core areas of marketing such as branding, customer insights, marketing ROI, digital marketing, CLM pricing, and sales and channel management.

About Periscope® by McKinsey
Founded in 2007, and now a part of the McKinsey Growth, Marketing & Sales practice, the Periscope® by McKinsey platform combines world-leading intellectual property, prescriptive analytics, and cloud-based tools with expert support and training. It’s a unique combination that drives revenue growth, both now and into the future. The platform offers a suite of Marketing & Sales solutions that accelerate and sustain commercial transformation for businesses. Periscope leverages its world-leading IP (largely from McKinsey but also other partners) and best-in-class technology to enable transparency into big data, create actionable insights and new ways of working that drive lasting performance improvement, and typically sustain a 2–7% increase in return on sales (ROS). With a truly global reach, the portfolio of solutions includes: Insight Solutions, Marketing Solutions, Customer Experience Solutions, Category Solutions, Pricing Solutions, Performance Solutions, and Sales Solutions. These are complemented by ongoing client service and custom capability-building programs.

To learn more about how Periscope’s solutions and experts are helping businesses continually drive better performance, visit www.mckinsey.com/periscope

For further information please contact:
Media Contacts
US : Digennaro Communications : MaryLiz Ghanem McKinsey-DiGennaro@digennaro-usa.com / 917-518-8422
UK : 3THINKRS : Ruth Jones / Becca Ross mckinsey@3thinkrs.com / 0208 0872843

GlobeNewswire Distribution ID 8844831

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) — With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” Citeline’s new Sitetrove Diversity Module marries robust site and investigator intelligence with patient age, race and gender data, enabling data-driven decision making to support the diversification of clinical trials.

The Diversity Module includes patient racial demographics from medical claims along with investigator gender data from the Centers for Medicare & Medicaid Services (CMS). The patient data are broken down by Asian, Black/African American, Hispanic, White and unknown. Sponsors will now be able to identify expert clinical investigators with relevant trial experience and who have access to diverse patient populations in one continuous workflow.

Enacted in December 2022, the U.S. 2023 omnibus spending bill requires diversity action plans for Phase 3 or pivotal clinical trials used by the FDA to determine the safety and efficacy of drugs. It reflects a concerted effort to reverse a growing trend: lack of diversity in clinical trials. In fact, according to a recent study, U.S. clinical trial diversity has dropped to its lowest level of the decade.

Citeline’s Sitetrove Diversity Module is designed to support Sponsors’ activities surrounding these imminent requirements, including feasibility, planning and investigator/site selection — all of which drive recruitment strategy. Beyond regulatory requirements, sponsors can leverage this demographic data to demonstrate a broader commitment to clinical trial diversity, equity, and inclusion.

“Clinical trial sponsors now have specific U.S. legal obligations, in addition to ethical ones, for improving diversity in their research studies,” said Dave Laky, General Manager of Clinical & Regulatory at Citeline. “While sponsors may worry about the challenges of recruiting underserved communities, pinpointing where diverse patients are being treated is a great first step towards enrolling these individuals. Our new Diversity Module is one example of how Citeline is actively investing in the expansion of our patient and provider demographic data to enable data-driven decision making.”

Citeline is also developing a Diversity API, scheduled for release later this quarter, that will allow users to analyze ICD10-specific patient counts by age, race and gender, for U.S. clinical investigators and organizations. Additional developments are planned for the Diversity Module in the coming months, including enhanced visualizations, enriched datasets, organization-level diversity insights, and patient landscapes outside the U.S.

Learn more about Citeline’s Sitetrove.

About Citeline
Citeline, a Norstella company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.

Citeline’s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted health science partners, visit Citeline.

Citeline PR contact:
Diffusion PR for Citeline
citeline@diffusionpr.com
(213) 318-4500

GlobeNewswire Distribution ID 8842677

Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery

SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop automation solutions for synthetic biology at SynBioBeta 2023 which is being held May 23-25 in Oakland, California.

Telesis Bio will present in two speaker sessions: Todd R. Nelson, Ph.D., CEO and Founder of Telesis Bio and David Brown, Ph.D., Director R&D, RNAimmune will present “Beyond COVID: Leveraging synthetic biology to advance the potential of mRNA-based vaccines” on Tuesday May 23^rd. RNAimmune will showcase the application of the BioXp platform for accelerating their vaccine discovery workflows. Daniel Gibson, Ph.D., CTO and Co-founder will present “Streamlining molecular biology workflows throughout biologics discovery” on Wednesday, May 24^th. His presentation will focus on the BioXp platform technology and updates on expanding capabilities in synthetic biology, library preparation for NGS and application of on-demand automated synthesis with SOLA EDS technology.

The award winning BioXp^® system and associated BioXp^® De novo and Select synthesis kits as well as NGS library prep kits provide a complete automated solution for accelerating many synthetic biology and genomics workflows throughout discovery. The system assists researchers in optimizing their discovery process by enabling sequence to screening in days, rather than weeks or months with alternative methods.

Telesis Bio will also present in two poster sessions at the conference: Qi Zhang, Ph.D. Scientist, R&D will present “Automated solutions for addressing mRNA synthesis bottlenecks in therapeutics discovery” and David Weiss, Director of Product Management will present “Construction & Sequence Verification of Custom Genomes: Using the BioXp to streamline design to test workflow” to showcase application of the NGS library preparation kits for plasmid sequencing on the BioXp platform.

For more information on Telesis Bio at SynBiobeta visit: https://telesisbio.com/synbiobeta-2023/

About Telesis Bio
Telesis Bio is empowering scientists with the ability to create novel, synthetic biology-enabled solutions for many of humanity’s greatest challenges. As inventors of the industry-standard Gibson Assembly^® method and the first commercial automated benchtop DNA and mRNA synthesis system, Telesis Bio is enabling rapid, accurate and reproducible writing of DNA and mRNA for numerous downstream markets. The award-winning BioXp^® system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. As a result, it delivers virtually error-free synthesis of DNA and RNA at scale within days and hours instead of weeks or months. Scientists around the world are using the technology in their own laboratories to accelerate the design-build-test paradigm for novel, high-value products for precision medicine, biologics drug discovery, vaccine and therapeutic development, genome editing, and cell and gene therapy. Telesis Bio is a public company based in San Diego. For more information, visit www.telesisbio.com.

Telesis Bio, the Telesis Bio logo, Gibson Assembly, and BioXp are trademarks of Telesis Bio Inc.

Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained herein are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include statements and guidance regarding Telesis Bio’s future financial performance as well as statements regarding the future release and success of new and existing products and services. Such statements are based on current assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. These risks and uncertainties, many of which are beyond our control, include risks described in the section entitled Risk Factors and elsewhere in our Quarterly Report on Form 10-Q, which was filed with the Securities and Exchange Commission on May 12, 2023, as amended on May 1, 2023. These forward-looking statements speak only as of the date hereof and should not be unduly relied upon. Telesis Bio disclaims any obligation to update these forward-looking statements.

Contact:
Jen Carroll
Vice President of Investor Relations
jen.carroll@telesisbio.com

GlobeNewswire Distribution ID 8843577